Dejan Mesner
-
- HIV Research and Treatment 3
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
-
- Immune Cell Function and Interaction 2
-
- Monoclonal and Polyclonal Antibodies Research 2
-
- Mosquito-borne diseases and control 2
-
- Viral Infections and Immunology Research 1
-
- Respiratory viral infections research 1
- Co-authors
- Clare JollyM. FairheadMelissa LeverGianluca VeggianiJun YanCarol V. RobinsonP. Anton van der MerweMark Howarth
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of the American Chemical Society (1 paper)Cell Reports (2 papers)
- Partner nations
- United KingdomGermanySouth Africa
In The Last Decade
Dejan Mesner
7 papers receiving 142 citations
Hit Papers
Peers
Comparison fields: 5 of 42
- Virology 19
- Infectious Diseases 49
- Immunology 28
- Modeling and Simulation 6
- Biotechnology 9
Countries citing papers authored by Dejan Mesner
This map shows the geographic impact of Dejan Mesner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dejan Mesner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dejan Mesner more than expected).
Fields of papers citing papers by Dejan Mesner
This network shows the impact of papers produced by Dejan Mesner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dejan Mesner. The network helps show where Dejan Mesner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dejan Mesner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariantsbreakdown → | 2024 | 34 |
| 3 | 2023 | 26 | |
| 4 | 2022 | 8 | |
| 5 | 2022 | 4 | |
| 6 | 2020 | 10 | |
| 7 | 2014 | 60 |
About Dejan Mesner
Dejan Mesner is a scholar working on Virology, Infectious Diseases and Immunology, having authored 7 papers that have together received 143 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), HIV Research and Treatment (3 papers), COVID-19 Clinical Research Studies (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Immune Cell Function and Interaction (2 papers), Mosquito-borne diseases and control (2 papers), Viral Infections and Immunology Research (1 paper) and Respiratory viral infections research (1 paper). The work is most often cited by research in Virology (19 citations), Infectious Diseases (49 citations) and Immunology (28 citations). Dejan Mesner has collaborated with scholars based in United Kingdom, Germany and South Africa. Frequent co-authors include Clare Jolly, M. Fairhead, Melissa Lever, Gianluca Veggiani, Jun Yan, Carol V. Robinson, P. Anton van der Merwe, Mark Howarth, Omer Dushek and Paola Bonfanti. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.